Liu, Y., Tsai, J., Weng, Y., & Hsu, F. (2020). Regorafenib suppresses epidermal growth factor receptor signaling-modulated progression of colorectal cancer. Elsevier.
Chicago Style (17th ed.) CitationLiu, Yu-Chang, Jai-Jen Tsai, Yueh-Shan Weng, and Fei-Ting Hsu. Regorafenib Suppresses Epidermal Growth Factor Receptor Signaling-modulated Progression of Colorectal Cancer. Elsevier, 2020.
MLA (8th ed.) CitationLiu, Yu-Chang, et al. Regorafenib Suppresses Epidermal Growth Factor Receptor Signaling-modulated Progression of Colorectal Cancer. Elsevier, 2020.
Warning: These citations may not always be 100% accurate.